Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

19 August 2026

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

78291 result(s) found, displaying 74751 to 74775

CSL ARGENTINA HUMAN COAGULATION FACTOR VIII FOR INJECTION 250IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL ARGENTINA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Biostate Europe, Human Coagulation FVIII/VWF complex 1000 IU (100 IU/mL) Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Biostate Europe, Human Coagulation FVIII/VWF complex 500 IU (50 IU/mL) Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Brazil Aleviate Human Coagulation Factor VIII 250 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Brazil Aleviate Human Coagulation Factor VIII 500 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Brazil Biostate Human Coagulation Factor VIII, freeze dried 1000 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Brazil Biostate Human Coagulation Factor VIII, freeze dried 500 IU (100 IU/mL) powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL COSTA RICA HUMAN COAGULATION FACTOR VIII FOR INJECTION 250IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL COSTA RICA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL HONG KONG BIOSTATE HUMAN COAGULATION FACTOR VIII freeze dried 250IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL HONG KONG BIOSTATE HUMAN COAGULATION FACTOR VIII freeze dried 500IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL HONG KONG PROTHROMBINEX-HT dried factor IX fraction powder for injection Batch 343 Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Hong Kong Prothrombinex-HT dried factor IX fraction powder for injection vial with diluent Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Indonesia Commercial Aleviate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Indonesia Commercial Aleviate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Indonesia Commercial Biostate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Indonesia Commercial Biostate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Korea Commercial Aleviate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Korea Commercial Aleviate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Korea Commercial Biostate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Korea Commercial Biostate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Limited - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Limited
CSL Malaysia Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU, Powder for injection (50 IU/mL FVIII) Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd
CSL Malaysia Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU, Powder for injection (50 IU/mL FVIII) Cancelled under Section 30(1)(c) of the Act

29 June 2015

Cancellation by sponsor

Requested by CSL Behring Australia Pty Ltd

Last updated

19 August 2026

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

CSL ARGENTINA HUMAN COAGULATION FACTOR VIII FOR INJECTION 250IU Cancelled under Section 30(1)(c) of the Act

CSL ARGENTINA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Cancelled under Section 30(1)(c) of the Act

CSL Biostate Europe, Human Coagulation FVIII/VWF complex 1000 IU (100 IU/mL) Cancelled under Section 30(1)(c) of the Act

CSL Biostate Europe, Human Coagulation FVIII/VWF complex 500 IU (50 IU/mL) Cancelled under Section 30(1)(c) of the Act

CSL Brazil Aleviate Human Coagulation Factor VIII 250 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL Brazil Aleviate Human Coagulation Factor VIII 500 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL Brazil Biostate Human Coagulation Factor VIII, freeze dried 1000 IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL Brazil Biostate Human Coagulation Factor VIII, freeze dried 500 IU (100 IU/mL) powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL COSTA RICA HUMAN COAGULATION FACTOR VIII FOR INJECTION 250IU Cancelled under Section 30(1)(c) of the Act

CSL COSTA RICA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Cancelled under Section 30(1)(c) of the Act

CSL HONG KONG BIOSTATE HUMAN COAGULATION FACTOR VIII freeze dried 250IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL HONG KONG BIOSTATE HUMAN COAGULATION FACTOR VIII freeze dried 500IU powder for injection vial Cancelled under Section 30(1)(c) of the Act

CSL HONG KONG PROTHROMBINEX-HT dried factor IX fraction powder for injection Batch 343 Cancelled under Section 30(1)(c) of the Act

CSL Hong Kong Prothrombinex-HT dried factor IX fraction powder for injection vial with diluent Cancelled under Section 30(1)(c) of the Act

CSL Indonesia Commercial Aleviate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

CSL Indonesia Commercial Aleviate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

CSL Indonesia Commercial Biostate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

CSL Indonesia Commercial Biostate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

CSL Korea Commercial Aleviate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

CSL Korea Commercial Aleviate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

CSL Korea Commercial Biostate, Human Coagulation Factor VIII for Injection 250 IU Cancelled under Section 30(1)(c) of the Act

CSL Korea Commercial Biostate, Human Coagulation Factor VIII for Injection 500 IU Cancelled under Section 30(1)(c) of the Act

CSL Limited - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

CSL Malaysia Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU, Powder for injection (50 IU/mL FVIII) Cancelled under Section 30(1)(c) of the Act

CSL Malaysia Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU, Powder for injection (50 IU/mL FVIII) Cancelled under Section 30(1)(c) of the Act